| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease
|
Jiao, Yue
|
|
|
179 |
C |
p. 76-86
|
artikel
|
| 2 |
Boosting capacity of a fourth dose BNT162b2 in cancer patients
|
Debie, Yana
|
|
|
179 |
C |
p. 121-123
|
artikel
|
| 3 |
BRAF inhibitor cessation prior to disease progression in metastatic melanoma: Long-term outcomes
|
Lee, Joanna
|
|
|
179 |
C |
p. 87-97
|
artikel
|
| 4 |
Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?
|
Roth, Gael S.
|
|
|
179 |
C |
p. 1-14
|
artikel
|
| 5 |
Circulating tumour DNA sequencing reveal mechanisms of resistance to BRAF-targeted therapies in BRAF-mutated gastrointestinal stromal tumour
|
Spalato Ceruso, Mariella
|
|
|
179 |
C |
p. 25-27
|
artikel
|
| 6 |
Germline findings in patients with advanced malignancies screened with paired blood–tumour testing for personalised treatment approaches
|
Roggia, Cristiana
|
|
|
179 |
C |
p. 48-55
|
artikel
|
| 7 |
Immune-related generalised oedema – A new category of adverse events with immune checkpoint inhibitors
|
Velev, Maud
|
|
|
179 |
C |
p. 28-47
|
artikel
|
| 8 |
Immunotherapy for brain metastases and primary brain tumors
|
Di Giacomo, Anna M.
|
|
|
179 |
C |
p. 113-120
|
artikel
|
| 9 |
Liver oligometastatic disease in synchronous metastatic gastric cancer patients: a nationwide population-based cohort study
|
Kroese, Tiuri E.
|
|
|
179 |
C |
p. 65-75
|
artikel
|
| 10 |
Position paper from the Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared decision making in patients with low-risk micro papillary thyroid carcinoma
|
Koot, Anna
|
|
|
179 |
C |
p. 98-112
|
artikel
|
| 11 |
Re: “Evolution of low HER2 expression between early and advanced-stage breast cancer”
|
Bravaccini, Sara
|
|
|
179 |
C |
p. 147-148
|
artikel
|
| 12 |
Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors
|
Riedel, Richard
|
|
|
179 |
C |
p. 124-135
|
artikel
|
| 13 |
Response to letter entitled: Re: “Evolution of low HER2 expression between early and advanced-stage breast cancer”
|
Tarantino, Paolo
|
|
|
179 |
C |
p. 149-151
|
artikel
|
| 14 |
Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort study
|
Imaji, Mihoko
|
|
|
179 |
C |
p. 15-24
|
artikel
|
| 15 |
Staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement
|
Guinot, A.
|
|
|
179 |
C |
p. 56-64
|
artikel
|
| 16 |
Testing for homologous recombination repair or homologous recombination deficiency for poly (ADP-ribose) polymerase inhibitors: A current perspective
|
Herzog, Thomas J.
|
|
|
179 |
C |
p. 136-146
|
artikel
|
Tijdschrift beschrijving